REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $100M
Founded date: 2014
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.07.2019 | - | $100M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадил... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной сви... | incrussia.... |
| 08.05.2023 | Revolution Medicines Reports First Quarter 2023 Financial Re... | /EIN News/ -- First Wave of Investigational RAS(ON) Inhibitors – RMC-6236 (RASMULTI), RMC-6291 (KRAS... | einpresswi... |
| 16.09.2022 | Why a top Roche scientist is leaving after 25 years to join ... | Martin Stahl will start as LifeMine Therapeutics' chief scientific officer on October 4. Martin Stah... | businessin... |
| 24.11.2021 | Revolution Medicines to Participate in 4th Annual Evercore I... | REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a... | marketscre... |
| 11.11.2021 | Revolution Medicines Reports Third Quarter Financial Results... | Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress RAS(ON... | marketscre... |
| 11.08.2021 | Revolution Medicines : Company Shows Continued Progress Demo... | Company Shows Continued Progress Demonstrating Differentiation of RAS(ON) Inhibitors, Targeting Addi... | marketscre... |
| 10.07.2019 | Revolution Medicines snags $100M to attack RAS-mutated cance... | Revolution Medicines raised $100 million in series C financing to advance a stable of drugs aiming a... | fiercebiot... |
| 20.12.2016 | Revolution Medicines Raises $25M in Series A Extension Finan... | Revolution Medicines, Inc., a Redwood City, Calif.-based company focused on frontier cancer targets ... | finsmes.co... |